Q-122 as a novel, non-hormonal, oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blind, placebo-controlled trial
- Resource Type
- Article
- Source
- In
The Lancet 12 November 2022 400(10364):1704-1711 - Subject
Primary Research Articles - Language
- ISSN
- 0140-6736